on a mobile?
vTap
    Loading...
 
 
Video
...GlaxoSmithKline Plc's Avandia diabetes drug versus Takeda Pharmaceutical Co.'s Actos. Graham told a meeting of FDA advisers today that Avandia should be removed from the market because of heart ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Pharmaceutical company
United Kingdom
Pioglitazone
Gaithersburg, Maryland
David Graham (epidemiologist)
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc's diabetes pill Avandia and the safety of Takeda Pharmaceutical Co.'s Actos. The panel decided that Avandia should remain on the market but be accompanied by new safety ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Cleveland Clinic
Pharmaceutical company
Steven Nissen
Rosiglitazone
Gaithersburg, Maryland
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United Kingdom
Pharmaceutical company
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Food and Drug Administration
Chief executive officer
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline Plc's U.S. pharmaceuticals unit, talks with Bloomberg's Michael McKee from Philadelphia about the company's study of its Avandia diabetes drug. An analysis of a Glaxo patient trial ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
United States
GlaxoSmithKline
United Kingdom
Diabetes mellitus
Pharmaceutical company
Michael Bloomberg
Anti-diabetic drug
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Chris Viehbacher, president of U.S. pharmaceuticals at GlaxoSmithKline Plc, talks with Bloomberg's Allan Dodds Frank in Gaithersburg, Maryland, about a Food and Drug Administration advisory panel's decision that Glaxo's diabetes pill Avandia should remain on the market with new safety warnings. The panel of medical specialists voted 22-1 at a meeting today. The advisers also voted 20-3 that Avandia boosts the risk of heart attacks. (Source: Bloomberg)
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Pharmaceutical company
Gaithersburg, Maryland
Diabetes mellitus
Combined oral contraceptive pill
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use